“Prostate-specific antigen and free prostate-specific antigen/prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer”, Baghdad J. Biochem. Appl. Biol. Sci., vol. 1, no. 01, pp. 18–26, Dec. 2020, doi: 10.47419/bjbabs.v1i01.28.